It later launched a hostile tender offer for its shares. Allergan has mounted a defense that includes its own cost-cutting plans, and has urged shareholders not to support the meeting or the deal. Judge David Carter in U.S. District Court, Central District of California, said in the documents that he would consider Allergan's request for an expedited schedule at a hearing rather than outside of "normal procedures," as requested. (Reporting by Caroline Humer; Editing by Jonathan Oatis)